✦ LIBER ✦

SMILING IN BLIND INFANTS AND THE ISSUE OF INNATE VS. ACQUIRED

✍ Scribed by D. G. Freedman

Book ID: 111114585
Publisher: John Wiley and Sons
Year: 1964
Tongue: English
Weight: 952 KB
Volume: 5
Category: Article
ISSN: 0021-9630
DOI: 10.1111/j.1469-7610.1964.tb02139.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain neuron gene expression in the orga

Brain neuron gene expression in the organization of innate and acquired behaviors

✍ K. V. Sudakov 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 533 KB

The critical role of type-1 innate and a

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

✍ Hiroaki Ikeda; Kenji Chamoto; Takemasa Tsuji; Yoshinori Suzuki; Daiko Wakita; Ts 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

Etiopathology and classification of acqu

Etiopathology and classification of acquired coagulation disorders in the newborn infant

✍ G�bel, U. ;Voss, H. ;Petrich, Chr ;J�rgens, H. ;Oliven, Anita 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 656 KB

Doxycycline vs. levofloxacin in the trea

Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia

✍ R. Mokabberi; A. Haftbaradaran; K. Ravakhah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Breast vs. bottle: differences in the gr

Breast vs. bottle: differences in the growth of Croatian infants

✍ Zlatko Mandić; Antonija Perl Pirički; Daniela Kenjerić; Branka Haničar; Igor Tan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Double-blind, multicenter, prospective r

Double-blind, multicenter, prospective randomized study of trospectomycin vs. clindamycin, both with aztreonam, in non-community acquired obstetric and gynecologic infections

✍ Ashwin Chatwani; Mark Martens; Jorge Blanco; Stanley Gall; Kira Przybylko; Charl 📂 Article 📅 1997 🏛 Hindawi Publishing Corporation 🌐 English ⚖ 62 KB

Objective: The purpose of this study was to compare the clinical efficacy and safety of trospectomycin sulfate with that of clindamycin phosphate, both with aztreonam, for the treatment of obstetric and gynecologic infections. Methods: In a double-blind, multicenter, prospective randomized study, 5